September is Leukemia and Lymphoma Awareness Month. An estimated 1,629,474 people in the United States (US) are living with or in remission from leukemia, lymphoma, myeloma, myelodysplastic syndromes ...

Infantile ALL occurs in children under age one. It’s a rare and aggressive leukemia that typically has a poor outlook. Treatment involves chemo and sometimes a stem cell transplant. Leukemia refers to ...

An international study published in the New England Journal of Medicine provides hope for chronic lymphocytic leukemia (CLL) patients with a new all-tablet treatment showing impressive results. The ...

Back from ASH 2025, Dr Suchitra Sundaram reports on notable frontline CLL data. Time‑limited pirtobrutinib combined with venetoclax and obinutuzumab produced high rates of undetectable minimal ...

Diagnostic challenges in leukemia—a fatal malignancy affecting blood cells—are immense due to its diverse manifestations and subtypes. Acute lymphoblastic leukemia is one of the most common types of ...

Most patients initiated full-dose ibrutinib, while reduced starting doses clustered in older, more comorbid, poorer ECOG cohorts, indicating clinician-driven personalization rather than cardiovascular ...

The origins of immunosuppression, neutropenia, and anemia in patients with chronic lymphocytic leukemia (CLL) are not fully understood. Because in patients with CLL, circulating exosomes, which ...

Borderline IGHV cases had a higher hazard for earlier treatment initiation than mutated IGHV, with median TTFT 91.1 months versus not reached for mutated and 41.1 months for unmutated. Reconstructed ...

New Delhi: Acute Lymphocytic Leukemia (ALL) is a serious type of cancer that affects the blood and bone marrow. It moves very quickly, meaning it needs fast and strong treatment. In ALL, the body ...

What Is It, and Why Does It Matter? The FDA has approved a new combination treatment for adults with certain cancers of the blood and lymphatic system. The targeted regimen combines Calquence ...

Leukemia refers to cancer of the blood cells and bone marrow. There are four main types, each associated with a different outlook and life expectancy. Healthcare professionals classify the different ...

Chronic lymphocytic leukemia (CLL) tends to have a better outlook than most other types of leukemia. About 88% of adults over the age of 20 years live for 5 years post-diagnosis, and some can live ...